Search results
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) is definitely on the radar of institutional investors who...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), it is...
NGM Biopharmaceuticals (NGM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) possesses the right combination of the two key ingredients for a likely...
Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 30%...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), then you'll have...
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) insider upped their holding by 68% earlier this year
Simply Wall St. via Yahoo Finance· 1 year agoLooking at NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM ) insider transactions over the last year, we...
NGM Biopharmaceuticals (NGM) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) saw its shares surge in the last session with trading volume being...
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 3 months agoNGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 10.81% and 91.75%,...
We Think NGM Biopharmaceuticals (NASDAQ:NGM) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Shareholders in NGM Biopharmaceuticals (NASDAQ:NGM) have lost 42%, as stock drops 6.5% this past...
Simply Wall St. via Yahoo Finance· 2 years agoInvestors can approximate the average market return by buying an index fund. While individual stocks...
NGM Biopharmaceuticals Inc (NGM) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 7 months agoNGM Biopharmaceuticals Inc (NASDAQ:NGM) reported a net loss of $28.8 million for Q3 2023, compared...
The NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Analysts Have Been Trimming Their Sales Forecasts
Simply Wall St. via Yahoo Finance· 2 years agoOne thing we could say about the analysts on NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) - they aren't...